John M. Mariadason

The ongoing objective of my work is to identify new and more effective treatments for patients affected with cancers of the colon, stomach and biliary tract.

I moved to New York to undertake postdoctoral training at the Montefiore Medical Center - Albert Einstein College of Medicine where I investigated the role of Wnt signaling in colon cancer progression and the use of gene expression profiling for predicting response of colon cancer cells to chemotherapy.

I established my independent laboratory at Albert Einstein in 2001 as Assistant Professor of Medicine and was appointed Associate Professor of Medicine in 2008. I returned home to Melbourne in 2008, joining the Ludwig Institute for Cancer Research as Head of the Oncogenic Transcription Laboratory.

I am currently Professor and Head of the Oncogenic Transcription Laboratory at the Olivia Newton-John Cancer Research Institute, where my research continues to be focused on the identification of new treatments for colon cancer, gastric cancer and cancers of biliary tract.